< Back to search
Filter
1

A Study of CTD402 in T-ALL/LBL Patients

for
Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Location: The Bronx NY, New York NY, Nashville TN, Chicago IL,
Sponsor: Imviva Bio

Sex: All

Age: 1+

Code: NCT07070219

Phase1, Phase2, Recruiting

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

for
Lymphoma, Sarcoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07058064

Recruiting

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

for
Hodgkin's Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1+

Code: NCT05355051

Phase2, Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

for
Non-Hodgkin Lymphoma, T-Cell Lymphoma,
Location: Austin TX
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07750886

Recruiting

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

for
Diffuse Large B-Cell Lymphoma (DLBCL)
Location: Rochester NY
Sponsor: Danielle Wallace

Sex: All

Age: 70+

Code: NCT06828991

Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

Outpatient Epcoritamab in Large B-cell Lymphoma

for
Relapsed Large B-cell Lymphoma,
Location: Boston MA, Newton MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06811272

Phase2, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Halifax, Quebec, Chicoutimi, Montreal, Saint-Jerôme,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase3, Recruiting

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

for
Lymphoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05294367

Early_phase1, Recruiting

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

for
Richter Syndrome, Diffuse Large B-Cell Lymphoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06863402

Phase2, Recruiting

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

for
T-cell Acute Lymphoblastic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 21

Code: NCT06561074

Phase2, Recruiting

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (SLL)
Location: Boston MA, New York NY
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06849713

Phase2, Recruiting

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL
Sponsor: Reem Karmali

Sex: All

Age: 18+

Code: NCT06723457

Phase2, Recruiting

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

for
Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07014293

Recruiting

Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Jennifer Woyach

Sex: All

Age: 70+

Code: NCT07685717

Phase2, Recruiting

Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma

for
Large B-cell Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07316010

Phase2, Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

for
Follicular Lymphoma
Location: Hackensack NJ, Durham NC, Lexington KY, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07634471

Phase2, Phase3, Recruiting

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

for
Lymphoid, Hodgkin Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07444632

Phase1, Recruiting

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

for
Leukemia, Lymphoma, Hematologic Malignancy
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06856226

Recruiting

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, T-cell Lymphoblastic Lymphoma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 15+

Code: NCT06446661

Recruiting